Difference between revisions of "Editorial Board"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Protected "Editorial Board": Locked page for editors ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
|||
Line 34: | Line 34: | ||
|- | |- | ||
|rowspan=8 style="background-color:#F0F0F0"|[[File:nkv.jpg|thumb|upright=0.4|center]] | |rowspan=8 style="background-color:#F0F0F0"|[[File:nkv.jpg|thumb|upright=0.4|center]] | ||
− | |rowspan=8|<big>Neeta K. Venepalli, MD, MBA<br>Chicago, IL</big> | + | |rowspan=8|<big>[[User:Neetavenepalli|Neeta K. Venepalli, MD, MBA]]<br>Chicago, IL</big> |
|style="background-color:#deebf7"|[[Anal cancer]] | |style="background-color:#deebf7"|[[Anal cancer]] | ||
|- | |- | ||
Line 54: | Line 54: | ||
|- | |- | ||
|rowspan=5 style="background-color:#F0F0F0"|[[File:aymen_elfiky.jpg|thumb|upright=0.4|center]] | |rowspan=5 style="background-color:#F0F0F0"|[[File:aymen_elfiky.jpg|thumb|upright=0.4|center]] | ||
− | |rowspan=5|<big>Aymen Elfiky, MD, MSc, MBA<br>Boston, MA</big><br>[https://www.linkedin.com/in/aymen-elfiky-15420873/ LinkedIn] | + | |rowspan=5|<big>[[User:Aymenelfiky|Aymen Elfiky, MD, MSc, MBA]]<br>Boston, MA</big><br>[https://www.linkedin.com/in/aymen-elfiky-15420873/ LinkedIn] |
|style="background-color:#deebf7"|[[Bladder cancer]] | |style="background-color:#deebf7"|[[Bladder cancer]] | ||
|- | |- | ||
Line 94: | Line 94: | ||
|- | |- | ||
|rowspan=4 style="background-color:#F0F0F0"|[[File:jim_chen.jpeg|thumb|upright=0.4|center]] | |rowspan=4 style="background-color:#F0F0F0"|[[File:jim_chen.jpeg|thumb|upright=0.4|center]] | ||
− | |rowspan=4|<big>James L. Chen, MD, MS<br>Columbus, OH</big><br>[https://www.linkedin.com/in/jameschen777/ LinkedIn] | + | |rowspan=4|<big>[[User:Jimchen|James L. Chen, MD, MS]]<br>Columbus, OH</big><br>[https://www.linkedin.com/in/jameschen777/ LinkedIn] |
|style="background-color:#deebf7"|[[Ewing's sarcoma]] | |style="background-color:#deebf7"|[[Ewing's sarcoma]] | ||
|- | |- | ||
Line 143: | Line 143: | ||
|style="background-color:#fee0d2"|[[Multiple myeloma]] | |style="background-color:#fee0d2"|[[Multiple myeloma]] | ||
|- | |- | ||
− | |style="background-color:#fee0d2"|[[Light-chain (AL) amyloidosis]] <br>Page editor: Samuel M. Rubinstein, MD (Nashville, TN) | + | |style="background-color:#fee0d2"|[[Light-chain (AL) amyloidosis]] <br>Page editor: [[User:Samuelrubinstein|Samuel M. Rubinstein, MD]] (Nashville, TN) |
|- | |- | ||
|style="background-color:#fee0d2"|[[Plasma cell leukemia]] | |style="background-color:#fee0d2"|[[Plasma cell leukemia]] | ||
Line 162: | Line 162: | ||
|- | |- | ||
|rowspan=6 style="background-color:#F0F0F0"|[[File:Shruti.jpg|thumb|upright=0.4|center]] | |rowspan=6 style="background-color:#F0F0F0"|[[File:Shruti.jpg|thumb|upright=0.4|center]] | ||
− | |rowspan=6|<big>Shruti Chaturvedi, MD, MSCI<br>Baltimore, MD</big><br>[https://www.linkedin.com/in/shruti-chaturvedi-bb83b126/ LinkedIn] | + | |rowspan=6|<big>[[User:Shrutichaturvedi|Shruti Chaturvedi, MD, MSCI]]<br>Baltimore, MD</big><br>[https://www.linkedin.com/in/shruti-chaturvedi-bb83b126/ LinkedIn] |
|style="background-color:#e5f5e0"|[[Aplastic anemia]] | |style="background-color:#e5f5e0"|[[Aplastic anemia]] | ||
|- | |- | ||
Line 176: | Line 176: | ||
|- | |- | ||
|rowspan=5 style="background-color:#F0F0F0"|[[File:Tillman_Benjamin-2.jpg|thumb|upright=0.4|center]] | |rowspan=5 style="background-color:#F0F0F0"|[[File:Tillman_Benjamin-2.jpg|thumb|upright=0.4|center]] | ||
− | |rowspan=5|<big>Benjamin Tillman, MD<br>Nashville, TN</big> | + | |rowspan=5|<big>[[User:Benjamintillman|Benjamin Tillman, MD]]<br>Nashville, TN</big> |
|style="background-color:#e5f5e0"|[[Hemophagocytic lymphohistiocytosis (HLH)]] | |style="background-color:#e5f5e0"|[[Hemophagocytic lymphohistiocytosis (HLH)]] | ||
|- | |- |
Revision as of 22:39, 14 December 2017
We are in the process of developing an editorial board of clinical experts, organized primarily by disease focus. Many disease sites now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Editor-in-Chief
Peter C. Yang, MD Boston, MA Twitter: Hem_Onc |
Deputy Editor
Jeremy L. Warner, MD, MS Nashville, TN Twitter: Hemoncwarner |